Healthscore 717·7 metrosupdated 1h ago
Recall of GLP-1 Injections Due to Sterility Concerns
Apothecary Pharma has recalled 23 vials of compounded GLP-1 injections, including tirzepatide, due to potential sterility issues. The FDA has classified the recall as Class II, indicating a risk of temporary health consequences.
Where it's breaking
Local coverage
Sources cited
Original outlets that filed on this story across the contributing metros. Click through for the underlying coverage.
What this is
A national rollup is a story Executive Producer detected breaking in multiple US metros at once. Each contributing market has its own deduplicated cluster from local broadcast, print, government, and community sources — this page links them together so a journalist can see the full national footprint. We are a pointer, not a publisher.Every linked headline goes back to the local cluster and from there to the original outlet — that's the URL to cite. A lead, not the law.